Carregant...
Improved nonviral cancer suicide gene therapy using survivin promoter-driven mutant Bax
Suicide gene vectors are being developed in many laboratories as an attractive approach to cancer therapy. However, the development of these therapies is hampered by safety concerns and limitations of efficacy. The use of tumor-specific promoters, such as survivin promoter, can provide much needed s...
Guardat en:
| Publicat a: | Cancer Gene Ther |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2009
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7219470/ https://ncbi.nlm.nih.gov/pubmed/19816523 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cgt.2009.63 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|